Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver Metastases
Conditions: Colorectal Cancer Interventions: Drug: Bevacizumab Combined With PD-1 Monoclonal Antibody Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Colorectal Cancer | Hospitals | Liver | Neoadjuvant Therapy | Research | Urology & Nephrology